Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment and Follow-up of Patients With KRAS G12C-mutated Metastatic Non-Small Cell Lung Cancer Who Received Sotorasib as Part of the French Early Access Program (ATU)

NCT05273047 is registered in ClinicalTrials.gov with Intergroupe Francophone de Cancerologie Thoracique as lead sponsor.

NCT NCT05273047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment and Follow-up of Patients With KRAS G12C-mutated Metastatic Non-Small Cell Lung Cancer Who Received Sotorasib as Part of the French Early Access Program (ATU)
Lead sponsor
Intergroupe Francophone de Cancerologie Thoracique
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2022
Completion date
December 31, 2024
Enrollment
458 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kras p.g12c, nsclc